[Bacterial resistance in antituberculosis chemotherapy; current status of the problem].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D000995:Antitubercular Agents; D001424:Bacterial Infections; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000628:therapy*
D000995:Antitubercular Agents; D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D013307:Streptomycin
MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS/therapy
La résistance bactérinne dans la chimiothérapie antituberculeuse; état actuel de la question.